Search
BridgeBio Oncology Therapeutics Ord Shs
BBOTAdd to Watchlist
3.990USD
-0.170-4.09%
Close 09-24 16:00（ET）
319.64MMarket Cap
19.79P/E TTM
BBOT Financials
See BridgeBio Oncology Therapeutics Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
319.64M
Dividend TTM
0.00
P/E TTM
19.79
EPS TTM
0.20
Revenue
--
Net Profit
7.60M
ROE
2.53%
ROA
2.44%
BridgeBio Oncology Therapeutics Ord Shs Earnings Date
Latest Release
Aug 11, 2026
EPS / Forecast
--/-0.57
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its current assets were 432.40M, with a year-on-year change of 172.47.
What are the total assets of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its total assets of BridgeBio Oncology Therapeutics Ord Shs were 448.38M, with a year-on-year change of 172.90.
What are the total liabilities of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its total liabilities of BridgeBio Oncology Therapeutics Ord Shs were 37.28M, with a year-on-year change of 90.42.
What is the total equity of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its total equity of BridgeBio Oncology Therapeutics Ord Shs was 411.10M, with a year-on-year change of 184.06.
What is the net operating income of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its net operating income of BridgeBio Oncology Therapeutics Ord Shs was -145.82M, with a year-on-year change of -80.33.
What is the net investment of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its net investment of BridgeBio Oncology Therapeutics Ord Shs was 73.33M, with a year-on-year change of 160.84.
What is the net financing of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its net financing of BridgeBio Oncology Therapeutics Ord Shs was 383.40M, with a year-on-year change of 85.86.
What is the Earnings Per Share (EPS) of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -4.30, with a year-on-year change of -1298.59.
What is the net income of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its net income was -134.04M, with a year-on-year change of -80.47.
What is the Return on Equity (ROE) of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its Return on Equity (ROE) was -115.33, with a year-on-year change of -1531.46.
What is the Return on Assets (ROA) of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -43.76, with a year-on-year change of -660.69.
What is the operating profit of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2025 earnings report, its operating profit was -145.82M, with a year-on-year change of -80.33.